Embiox ApS: Financial statements 2024
CVR: 42521310
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
Embiox ApS (CVR 42521310) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 779,186 and a net result of DKK 54,539 compared with DKK 91,291 the year before. That is a decrease of 3.9% compared with the year before. Equity in the 2024 report amounted to DKK 96,837. The solvency ratio was 22.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 779,186
- Profit/Loss
- DKK 54,539
- Equity
- DKK 96,837
- Total Assets
- DKK 434,833
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 779 t. | 55 t. | 97 t. | 1 |
| 2023 | - | 811 t. | 91 t. | 132 t. | 1 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Embiox ApS
Embiox ApS is a Danish company of the type Anpartsselskab based in Støvring, founded in 2021. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Daniel Mandrup. The company is owned by DMandrup Holding ApS. In 2025, the company reported a gross profit of DKK 568,503 and a net result of DKK 73,331 compared with DKK 54,539 the year before. Equity in the 2025 report amounted to DKK 120,168.